Latest / Denver Regenerative Medicine

Retatrutide Explained — Why the Next-Gen GLP-1 Isn't Available Yet
Retatrutide explained: what the triple agonist actually does, and why it isn't available yet. Denver Regenerative Medicine breaks down how retatrutide targets GLP-1, GIP, and the glucagon receptor, what its investigational status means, and why medically supervised GLP-1 therapy matters more than chasing an unapproved peptide online. Serving Denver, Fort Collins, and Colorado Springs.
Learn more about approved GLP-1 options: https://denverregenerativemedicine.com/tirzepatide-weight-loss-injections/
Why sourcing matters…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.